A pilot study of the feasibility of empagliflozin in recent-onset type 1 diabetes
Introduction: Sodium-glucose linked transporter (SGLT) inhibitors could improve glycaemia and simplify insulin regimens in recent-onset type 1 diabetes (T1D), provided they were well-tolerated and safe. This study aimed to determine the feasibility and safety of a SGLT inhibitor for the treatment of...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-03-01
|
| Series: | Metabolism Open |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589936820300013 |